Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR9Q2 Inhibitors

OR9Q2 is a member of the olfactory receptor family, which plays a critical role in the sense of smell. These receptors are part of a large class of proteins known as G protein-coupled receptors (GPCRs), which detect molecules outside the cell and trigger internal signal transduction pathways and cellular responses. The olfactory receptors, including OR9Q2, are predominantly expressed in the sensory neurons of the olfactory epithelium, where they are responsible for the detection of volatile chemical signals, which are interpreted by the brain as different odors. The specific function and the spectrum of odorants that OR9Q2 responds to are not well-characterized, as is the case with many olfactory receptors. However, understanding the regulation of the expression of genes such as OR9Q2 is crucial for comprehending how odors are perceived and processed by the olfactory system. A variety of chemicals can potentially downregulate or inhibit the expression of the OR9Q2 gene at the transcriptional or post-transcriptional level. One such compound is Actinomycin D, which binds to DNA and inhibits the transcription process by preventing RNA polymerase from effectively copying the OR9Q2 gene into messenger RNA. Another compound, Cycloheximide, functions by blocking the translation process, thus inhibiting protein synthesis, including that of OR9Q2. Similarly, Rapamycin targets the mTOR pathway, which is essential for protein synthesis and cell proliferation, potentially leading to a decrease in OR9Q2 expression. Histone deacetylase inhibitors like Trichostatin A and Sodium Butyrate modify chromatin structure, potentially affecting the accessibility of the OR9Q2 gene to the transcriptional machinery and thus altering its expression. Furthermore, compounds such as 5-Azacytidine and Mithramycin A can alter DNA methylation and DNA binding to transcription factors, respectively, each leading to potential reductions in OR9Q2 expression. These compounds illustrate the diverse molecular mechanisms through which chemical agents can regulate the expression of genes critical to olfactory function.

Items 11 to 12 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Spironolactone

52-01-7sc-204294
50 mg
$107.00
3
(1)

Spironolactone alters the transcriptional regulation of hormone-responsive genes, which could lead to decreased expression of downstream targets such as OR9Q2.

Tamoxifen

10540-29-1sc-208414
2.5 g
$256.00
18
(2)

Tamoxifen binds to estrogen receptors and alters the transcriptional activity of estrogen-responsive elements, potentially leading to decreased OR9Q2 expression.